BioSpace News Archive

Creyon Bio, Inc. announced today that David Dimmock , M.D., has joined the company as Chief Medical Officer.

BiondVax Pharmaceuticals Ltd. today announced the signing of definitive agreements with the Max Planck Society, the parent organization of the Max Planck Institute for Multidisciplinary Sciences (MPI), and the University Medical Center Göttingen (UMG), both in Germany, to enter into a strategic collaboration for the development of innovative nanosized antibodies (NanoAbs).

Verastem Oncology today announced that Channing Der, PhD, has been appointed to its Scientific Advisory Board.

AstraZeneca has partnered with The National Fish and Wildlife Foundation (NFWF) to plant and sustain one million trees in the United States by the end of 2025.

Taysha Gene Therapies, Inc. today announced that it will report its financial results for the fourth quarter and full-year ended December 31, 2021, and host a corporate update conference call and webcast on Thursday, March 31, 2022, at 8:00 AM Eastern Time.

Moderna today announced clinical and program updates demonstrating expansion and advancement of its mRNA pipeline.

Calliditas Therapeutics AB announced that CEO Renée Aguiar-Lucander has subscribed for 175,000 shares through Calliditas’ warrant program 2018/2022.

Milestone Pharmaceuticals Inc. today reported financial results for the fourth quarter and year ended December 31, 2021.

Vanqua Bio today announced that the company will participate in the Stifel 2022 CNS Day Conference, which is being held virtually March 28-29.

Dante Labs announces the establishment of the first of its Medical Genomics Boards, strengthening the Company’s mission and research activity in this new frontier of healthcare, using genomics to promote prevention and treatment.